m+Medelevator.RU
← Поиск публикаций
Immunity · 2020

Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses.

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Guthmiller Jenna J, Lan Linda Yu-Ling, Fernández-Quintero Monica L, Han Julianna, Utset Henry A, Bitar Dalia J, Hamel Natalie J, Stovicek Olivia, Li Lei, Tepora Micah, Henry Carole, Neu Karlynn E, Dugan Haley L, Borowska Marta T, Chen Yao-Qing, Liu Sean T H, Stamper Christopher T, Zheng Nai-Ying, Huang Min, Palm Anna-Karin E, García-Sastre Adolfo, Nachbagauer Raffael, Palese Peter, Coughlan Lynda, Krammer Florian, Ward Andrew B, Liedl Klaus R, Wilson Patrick C

Аннотация

Polyreactivity is the ability of a single antibody to bind to multiple molecularly distinct antigens and is a common feature of antibodies induced upon pathogen exposure. However, little is known about the role of polyreactivity during anti-influenza virus antibody responses. By analyzing more than 500 monoclonal antibodies (mAbs) derived from B cells induced by numerous influenza virus vaccines and infections, we found mAbs targeting conserved neutralizing influenza virus hemagglutinin epitopes were polyreactive. Polyreactive mAbs were preferentially induced by novel viral exposures due to their broad viral binding breadth. Polyreactivity augmented mAb viral binding strength by increasing antibody flexibility, allowing for adaption to imperfectly conserved epitopes. Lastly, we found affinity-matured polyreactive B cells were typically derived from germline polyreactive B cells that were preferentially selected to participate in B cell responses over time. Together, our data reveal that polyreactivity is a beneficial feature of antibodies targeting conserved epitopes.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты